Keith Tapper
Stock Analyst at BMO Capital
(0)
# 4780
Out of 5,332 analysts
6
Total ratings
16.67%
Success rate
-23.99%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NGNE Neurogene | Maintains: Outperform | 45 16 | 13 | 23.08% | 4 | Apr 14, 2025 | |
TSHA Taysha Gene Therapie... | Initiates Coverage On: Outperform | 5 | 1.91 | 161.78% | 1 | Jun 27, 2024 | |
ACAD ACADIA Pharmaceutica... | Initiates Coverage On: Outperform | 31 | 14.56 | 112.91% | 1 | Jun 27, 2024 |